ACIP votes to recommend Novavax COVID-19 vaccine for US adults

The CDC’s vaccine advisory committee on Tuesday voted to recommend Novavax’s two-dose COVID-19 vaccine for adults in the United States.
The Advisory Committee on Immunization Practices voted unanimously 12-0 to recommend the adjuvanted, recombinant spike protein nanoparticle vaccine for anyone aged 18 years or older.
The recommendation will become official when CDC Director Rochelle P. Walensky, MD, MPH, endorses it. 
Data shared during the meeting showed that approximately 26 million to 37 million U.S. adults have not received a single dose of COVID-19 vaccine, despite

The CDC’s vaccine advisory committee on Tuesday voted to recommend Novavax’s two-dose COVID-19 vaccine for adults in the United States.
The Advisory Committee on Immunization Practices voted unanimously 12-0 to recommend the adjuvanted, recombinant spike protein nanoparticle vaccine for anyone aged 18 years or older.
The recommendation will become official when CDC Director Rochelle P. Walensky, MD, MPH, endorses it. 
Data shared during the meeting showed that approximately 26 million to 37 million U.S. adults have not received a single dose of COVID-19 vaccine, despite